Compare DLXY & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DLXY | HKPD |
|---|---|---|
| Founded | 2007 | 2016 |
| Country | Singapore | Hong Kong |
| Employees | N/A | N/A |
| Industry | | Other Pharmaceuticals |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6M | 10.6M |
| IPO Year | 2025 | 2025 |
| Metric | DLXY | HKPD |
|---|---|---|
| Price | $0.88 | $0.78 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 55.0K | 49.4K |
| Earning Date | 12-30-2025 | 02-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1077.13 | N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $273,155,000.00 | $20,313,818.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.56 | ★ N/A |
| Revenue Growth | N/A | ★ 21.72 |
| 52 Week Low | $0.61 | $0.68 |
| 52 Week High | $7.16 | $3.79 |
| Indicator | DLXY | HKPD |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 41.79 |
| Support Level | N/A | $0.76 |
| Resistance Level | N/A | $0.90 |
| Average True Range (ATR) | 0.00 | 0.06 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 0.00 | 40.43 |
Delixy Holdings Ltd a holding company that operates through subsidiary. It is engaged in the trading of oil-related products, which can be categorized into crude oil, and oil-based products such as naphtha, motor gasoline, gas oil, fuel oil, asphalt, base oil, and other petrochemicals. The company has two reportable segments: the Sale of crude oil and the Sale of oil-based products. Key revenue is generated from the Sale of crude oil.
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.